Cargando…

Association Between p.R4810K Variant and Long-Term Clinical Outcome in Patients With Moyamoya Disease

Objective: To estimate the association between p. R4810K variant and clinical outcomes of patients with moyamoya disease (MMD). Methods: The p.R4810K genetic variant was genotyped among 498 Chinese patients with MMD conducted from June 1, 2012, to June 31, 2017. Data was obtained by retrospective ch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ge, Peicong, Ye, Xun, Liu, Xingju, Deng, Xiaofeng, Wang, Rong, Zhang, Yan, Zhang, Dong, Zhang, Qian, Zhao, Jizong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603092/ https://www.ncbi.nlm.nih.gov/pubmed/31293503 http://dx.doi.org/10.3389/fneur.2019.00662

Ejemplares similares

Different subtypes of collateral vessels in hemorrhagic moyamoya disease with p.R4810K variant
por: Ge, Peicong, et al.
Publicado: (2020)

Angiographic Outcomes of Direct and Combined Bypass Surgery in Moyamoya Disease
por: Ge, Peicong, et al.
Publicado: (2019)

Hyperhomocysteinemia Is a Predictor for Poor Postoperative Angiogenesis in Adult Patients With Moyamoya Disease
por: He, Qiheng, et al.
Publicado: (2022)

Postoperative collateral formation after indirect bypass for hemorrhagic moyamoya disease
por: Ge, Peicong, et al.
Publicado: (2020)

Predictive role of heterozygous p.R4810K of RNF213 in the phenotype of Chinese moyamoya disease
por: Wang, Yue, et al.
Publicado: (2020)

Significant association of RNF213 p.R4810K, a moyamoya susceptibility variant, with coronary artery disease
por: Morimoto, Takaaki, et al.
Publicado: (2017)

Association between systemic immune-inflammatory markers and the risk of moyamoya disease: a case-control study
por: Liu, Wei, et al.
Publicado: (2023)

Genotype–Phenotype Correlation of the RNF213 R4810K Variant in Moyamoya Disease
por: Ok, Taedong, et al.
Publicado: (2023)

Genetic analysis of RNF213 p.R4810K variant in non-moyamoya intracranial artery stenosis/occlusion disease in a Chinese population
por: Zhang, Tong, et al.
Publicado: (2017)

Gut microbiota in adults with moyamoya disease: characteristics and biomarker identification
por: Yu, Xiaofan, et al.
Publicado: (2023)

Plasma urea cycle metabolite levels and the risk of moyamoya disease
por: Yu, Xiaofan, et al.
Publicado: (2023)

Serum Kynurenic Acid and Kynurenine Are Negatively Associated with the Risk of Adult Moyamoya Disease
por: Yu, Xiaofan, et al.
Publicado: (2022)

Identification of Alpha Thalassemia, RNF213 p.R4810K and PROC p.R189W among Children with Moyamoya Disease/Syndrome
por: Thampratankul, Lunliya, et al.
Publicado: (2022)

Risk factors for postoperative ischemic complications in pediatric moyamoya disease
por: Deng, Xiaofeng, et al.
Publicado: (2021)

RNF213 R4810K Variant in Suspected Unilateral Moyamoya Disease Predicts Contralateral Progression
por: Ok, Taedong, et al.
Publicado: (2022)

Cognitive Performance Profile in Pediatric Moyamoya Disease Patients and Its Relationship With Regional Cerebral Blood Perfusion
por: Li, Jiaxi, et al.
Publicado: (2019)

Digital subtraction angiographic characteristics of progression of moyamoya disease 6 months prior to surgical revascularisation
por: Ge, Peicong, et al.
Publicado: (2020)

Filamin A Variant as a Possible Second-Hit Gene Promoting Moyamoya Disease–like Vascular Formation Associated With RNF213 p.R4810K Variant
por: Ikeuchi, Yasuhito, et al.
Publicado: (2022)

An analysis of the demographic history of the risk allele R4810K in RNF213 of moyamoya disease
por: Koganebuchi, Kae, et al.
Publicado: (2021)

Correlation of Serum N-Acetylneuraminic Acid with the Risk of Moyamoya Disease
por: Liu, Chenglong, et al.
Publicado: (2023)

Circulating choline pathway nutrients and risk of moyamoya disease
por: Ge, Peicong, et al.
Publicado: (2022)

Association of circulating branched-chain amino acids with risk of moyamoya disease
por: Zeng, Chaofan, et al.
Publicado: (2022)

Hypo-high density lipoproteinemia is a predictor for recurrent stroke during the long-term follow-up after revascularization in adult moyamoya disease
por: Yu, Xiaofan, et al.
Publicado: (2022)

Ethnic variation and the relevance of homozygous RNF 213 p.R4810.K variant in the phenotype of Indian Moya moya disease
por: K., Arun, et al.
Publicado: (2020)

RNF213 p.R4810K Variant Carriers with Intracranial Arterial Stenosis Have a Low Atherosclerotic Burden
por: Ohara, Mariko, et al.
Publicado: (2022)

Observation of p.R4810K, a Polymorphism of the Mysterin Gene, the Susceptibility Gene for Moyamoya Disease, in Two Female Japanese Diabetic Patients with Familial Partial Lipodystrophy 1
por: Iwanishi, Masanori, et al.
Publicado: (2020)

Correction: Ethnic variation and the relevance of homozygous RNF 213 p.R4810.K variant in the phenotype of Indian Moya moya disease
Publicado: (2021)

Association Between Ultrasound Parameters and History of Ischemic or Hemorrhagic Stroke in Patients With Moyamoya Disease
por: Zheng, Shuai, et al.
Publicado: (2021)

RNF213 p.R4810K (c.14429G > A) Variant Determines Anatomical Variations of the Circle of Willis in Cerebrovascular Disease
por: Eto, Futoshi, et al.
Publicado: (2021)

Effect of the RNF213 p.R4810K Variant on the Progression of Intracranial Artery Stenosis: A 15-Year Follow-up Study
por: Okazaki, Shuhei, et al.
Publicado: (2022)

Frequency of the moyamoya-related RNF213 p.Arg4810Lys variant in 1,516 Korean individuals
por: Jang, Mi-Ae, et al.
Publicado: (2015)

The Role of RNF213 4810G>A and 4950G>A Variants in Patients with Moyamoya Disease in Korea
por: Park, Young Seok, et al.
Publicado: (2017)

Biochemical and Functional Characterization of RNF213 (Mysterin) R4810K, a Susceptibility Mutation of Moyamoya Disease, in Angiogenesis In Vitro and In Vivo
por: Kobayashi, Hatasu, et al.
Publicado: (2015)

Amplified Risk of Intracranial Artery Stenosis/Occlusion Associated With RNF213 p.R4810K in Familial Hypercholesterolemia
por: Noda, Kotaro, et al.
Publicado: (2023)

Association between methionine sulfoxide and risk of moyamoya disease
por: Li, Junsheng, et al.
Publicado: (2023)

MMP-9 as a Biomarker for Predicting Hemorrhagic Strokes in Moyamoya Disease
por: Lu, Junlin, et al.
Publicado: (2021)

Integrated analysis of the association between methionine cycle and risk of moyamoya disease
por: Li, Junsheng, et al.
Publicado: (2023)

Clinical Significance of Ultrasound-Based Hemodynamic Assessment of Extracranial Internal Carotid Artery and Posterior Cerebral Artery in Symptomatic and Angiographic Evolution of Moyamoya Disease: A Preliminary Study
por: Zheng, Shuai, et al.
Publicado: (2021)

Hemorrhagic Transformation in Ischemic Moyamoya Disease: Clinical Characteristics, Radiological Features, and Outcomes
por: Lu, Junlin, et al.
Publicado: (2020)

Comparison of Long-Term Effect Between Direct and Indirect Bypass for Pediatric Ischemic-Type Moyamoya Disease: A Propensity Score-Matched Study
por: Zhao, Yahui, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o6qc7tkrcj180014552m9ovr23